1. Home
  2. LSTA vs MGRX Comparison

LSTA vs MGRX Comparison

Compare LSTA & MGRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LSTA
  • MGRX
  • Stock Information
  • Founded
  • LSTA 1980
  • MGRX 2021
  • Country
  • LSTA United States
  • MGRX United States
  • Employees
  • LSTA N/A
  • MGRX N/A
  • Industry
  • LSTA Misc Health and Biotechnology Services
  • MGRX Computer Software: Prepackaged Software
  • Sector
  • LSTA Health Care
  • MGRX Technology
  • Exchange
  • LSTA Nasdaq
  • MGRX Nasdaq
  • Market Cap
  • LSTA 20.9M
  • MGRX 23.3M
  • IPO Year
  • LSTA N/A
  • MGRX 2023
  • Fundamental
  • Price
  • LSTA $2.52
  • MGRX $2.45
  • Analyst Decision
  • LSTA Strong Buy
  • MGRX
  • Analyst Count
  • LSTA 2
  • MGRX 0
  • Target Price
  • LSTA $23.50
  • MGRX N/A
  • AVG Volume (30 Days)
  • LSTA 23.5K
  • MGRX 177.2K
  • Earning Date
  • LSTA 11-11-2025
  • MGRX 11-13-2025
  • Dividend Yield
  • LSTA N/A
  • MGRX N/A
  • EPS Growth
  • LSTA N/A
  • MGRX N/A
  • EPS
  • LSTA N/A
  • MGRX N/A
  • Revenue
  • LSTA $1,070,000.00
  • MGRX $516,030.00
  • Revenue This Year
  • LSTA N/A
  • MGRX N/A
  • Revenue Next Year
  • LSTA N/A
  • MGRX N/A
  • P/E Ratio
  • LSTA N/A
  • MGRX N/A
  • Revenue Growth
  • LSTA N/A
  • MGRX N/A
  • 52 Week Low
  • LSTA $1.87
  • MGRX $1.32
  • 52 Week High
  • LSTA $4.20
  • MGRX $6.15
  • Technical
  • Relative Strength Index (RSI)
  • LSTA 54.15
  • MGRX 58.43
  • Support Level
  • LSTA $2.36
  • MGRX $2.04
  • Resistance Level
  • LSTA $2.62
  • MGRX $2.66
  • Average True Range (ATR)
  • LSTA 0.18
  • MGRX 0.26
  • MACD
  • LSTA 0.03
  • MGRX 0.01
  • Stochastic Oscillator
  • LSTA 72.08
  • MGRX 71.19

About LSTA Lisata Therapeutics Inc.

Lisata Therapeutics Inc is a clinical-stage pharmaceutical company dedicated to the discovery, development, and commercialization of therapies for the treatment of solid tumors and other diseases. Its investigational product, certepetide, is designed to activate a novel uptake pathway that allows co-administered or tethered (i.e., molecularly bound) anti-cancer drugs to target and penetrate solid tumors more effectively. The group has one operating segment, the research and development of its investigational drug product.

About MGRX Mangoceuticals Inc.

Mangoceuticals Inc focuses on developing, marketing, and selling a variety of men's wellness products and services through a telemedicine platform. The company's platform provides access for customers to a licensed pharmacy for online fulfillment and distribution of certain medications that may be prescribed as part of telehealth consultations, including Mango ED products.

Share on Social Networks: